Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Kytril, Granisol, Sancuso
Granisetron is a serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. It belongs to the antiemetic class of drugs and works by blocking the action of serotonin, a natural substance that can trigger nausea and vomiting.
Used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery.
Outcome:
Reduced antiemetic effect of granisetron
Mechanism:
Pharmacodynamic interaction
Outcome:
Additive central nervous system depression
Mechanism:
Pharmacodynamic interaction
Outcome:
May slightly decrease granisetron absorption
Mechanism:
Altered gastrointestinal pH
Most likely new formulation: Extended-release oral formulation (Year 2025, 75% confidence)
Based on usage trends and clinical trial data, there is a 90% likelihood that granisetron will maintain its current FDA approval status.
Antiemetic, Serotonin 5-HT3 Receptor Antagonist
Carbazole derivative